ENO1 and benign neoplasm: Cytoplasmic staining is in line with its role as a glycolytic enzyme, while nuclear localization—reported predominantly in benign tumors—is linked to its isoform MBP-1, which binds to C-myc, inactivating it, thus acting as a tumor suppressor [35].